You are currently viewing Surveillance for enteric fever in Asia project (SEAP) Phase II

Surveillance for enteric fever in Asia project (SEAP) Phase II

Project Summary

Enteric fever is a common collective term for two similarly transmitted Salmonellosis infections; typhoid and paratyphoid fevers, respectively causing an estimated 26 million and 5 million illnesses with 190,000 enteric fever deaths each year globally. It remains a major public health problem in low income countries, particularly in developing countries of Asia and sub-Saharan Africa, where a large proportion of the population lacks access to clean water, sanitation, and hygiene infrastructure. Although the proportion of typhoid fever cases represents the majority of enteric fever cases in most parts of the world, several recent studies have shown an increase in Paratyphi A infections in Asia, with paratyphoid fever rates approaching or surpassing typhoid. Complex geographical variations in disease incidence, number and severity of complications, and distribution and characterization of antimicrobial resistance further highlight the burden of disease Diagnosis and treatment of enteric fever poses a challenge. Clinically, the two forms of enteric fever are indistinguishable and manifest as a febrile illness with non-specific symptoms resembling other illnesses endemic in the same regions, such as scrub and murine typhus, and leptospirosis. Improved diagnostic tests for typhoid are needed. Bacterial culture, which remains the gold standard for laboratory diagnosis, is only 40 – 60% sensitive for blood specimens and existing serodiagnostic tests perform even less well with lower specificity and/or sensitivity. Appropriate antibiotics are required for treatment; however, the prevalence of resistance to available antibiotics is increasing, therefore resulting in higher morbidity, mortality and cost of treatment. Intestinal perforation is the most common and serious complication, but several others, including neurological manifestations, are well documented. Existing typhoid fever burden estimates from Asia have relied upon active or passive augmented household based studies for the early detection of typhoid fever. Reliable and up-to-date data on enteric fever are often absent, even in endemic countries. Data gathered from small-scale studies, such as hospital case reviews, which often focus on disease incidence in urban areas, have very limited generalizability. Significant challenges remain in measuring complications and death due to typhoid fever. A systematic review produced by International Vaccine Institute from 1991 to 2011 found a mortality rate of 15.5% in hospitalized cases of intestinal perforation. However, a number of small prospective, community-based studies of febrile illness and blood culture-confirmed typhoid fever have found few complications and long-term sequelae and limited case fatality from typhoid. These considerations illustrate the need to focus on severe disease and its outcomes in order to increase the accuracy of disease burden estimates that translate into policy-making and public health action. This project is part of a larger enteric fever study (Surveillance of Enteric Fever in Asia Project) Phase II being conducted in several Asian countries, including Nepal, Bangladesh, and Pakistan. The SEAP Phase I study was conducted by another group of investigators, and the preliminary findings are forthcoming in the Journal of Infectious Diseases. It reported many cases of typhoid in Nepal and described age distribution of cases, but did not report population-based incidence estimates, which is the main goal of Phase II. The goal is to characterize the burden, costs of illness, diagnostics, outcomes and antimicrobial resistance for enteric fever, to inform interventions for enteric fever control including new conjugate vaccines. The larger study is being led by the Sabin Vaccine Institute, but each country is adapting the study methods to its local conditions. The surveillance component of SEAP will also form the platform for an assessment of other causes of undifferentiated fever, such as typhus, other rickettsia and leptospirosis.

Study Duration

From 09/05/2016 – 10/31/2019

Objectives

The objective of SEAP Phase II is to characterize the burden of enteric fever in Nepal, including clinical manifestations, severity of illness, long-term sequelae of illness, antimicrobial resistance patterns of enteric fever isolates, evaluate new diagnostics, and the cost of illness.Evaluate alternative diagnostics approach like follow-up home visits of patients to map household locations via GPS for spatial mapping of pathogen occurrence and sero-epidemiologic markers for enteric fever and other undifferentiated febrile illnesses

Outcomes

Our incidence estimates—crude, unadjusted, and adjusted rates—show a substantial burden of enteric fever. Crude incidence rates are a minimal estimate for enteric fever incidence and are highly sensitive to the coverage of surveillance facilities, which varied across catchment areas. Adjusted rates varied by country, between different communities in a country. The high rates of hospitalization indicate considerable morbidity and economic impact, highlighting the need for control measures, including the implementation of TCV. The adjusted incidence of disease was higher among individuals 5 years and older, highlighting the importance of understanding local epidemiology for a tailored and more effective vaccination strategy in Nepal.

Team Members

Principal Investigator(s): Dr. Dipesh Tamrakar, Prof. Dr. Jason Andrews

Co-Investigator(s): Prof. Dr. Rajeev Shrestha, Dr. Sailesh Pradhan, Dr. Nirajan Bhusal, Dr. Jyotshana Shrestha

Project Coordinator: Ms. Krista Vaidya, Mr. Jivan Shakya

Research Assistant(s): Mr. Shiva Ram Naga, Mr. Sabin Bikram Shahi, Ms. Aarjya Tara Bajrachrya, Mr. Sudan Maharjan, Ms. Neeru Shrestha, Ms. Melina Thapa, Mr. Suraj Jakibanjar, Ms. Barsha Thapa, Ms. Sneha Shrestha, Ms. Mudita Shrestha, Ms. Bikram Adhikari, Mr. Puspa Raj Bhatta, Mr. Rupesh Khadka, Ms. Sangita Duwal, Ms. Swekshya Karmacharya, Ms. Devi Dhital, Mr. Parashar Khadka, Ms. Subhadra Khadka.

Data Manager: Mr. Dipesh Khadka 

Supported by: Sabin Vaccine Institute, USA

Collaborating Partner: Stanford University, San Francisco, USA

Publications

1. Garrett DO, Longley AT, Aiemjoy K, Yousafzai MT, Hemlock C, Yu AT, et al. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project. The Lancet Global Health. 2022 Jul;10(7):e978–88.

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(22)00119-X/fulltext#:~:text=The%20Surveillance%20for%20Enteric%20Fever%20in%20Asia%20Project%20(SEAP)%2C,Bangladesh%2C%20Nepal%2C%20and%20Pakistan. 

2. Yu AT, Shakya R, Adhikari B, Tamrakar D, Vaidya K, Maples S, et al. A Cluster-based, Spatial-sampling Method for Assessing Household Healthcare Utilization Patterns in Resource-limited Settings. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S239–47.

https://academic.oup.com/cid/article/71/Supplement_3/S239/6013561. 

3. Mejia N, Abimbola T, Andrews JR, Vaidya K, Tamrakar D, Pradhan S, et al. Typhoid and Paratyphoid Cost of Illness in Nepal: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S306–18.

https://academic.oup.com/cid/article/71/Supplement_3/S306/6013567. 

4. Vaidya K, Aiemjoy K, Qamar FN, Saha SK, Tamrakar D, Naga SR, et al. Antibiotic Use Prior to Hospital Presentation Among Individuals With Suspected Enteric Fever in Nepal, Bangladesh, and Pakistan. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S285–92.

https://academic.oup.com/cid/article/71/Supplement_3/S285/6013563. 

5. Aiemjoy K, Tamrakar D, Saha S, Naga SR, Yu AT, Longley A, et al. Diagnostic Value of Clinical Features to Distinguish Enteric Fever From Other Febrile Illnesses in Bangladesh, Nepal, and Pakistan. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S257–65.

https://academic.oup.com/cid/article/71/Supplement_3/S257/6013564. 

6. Andrews JR, Vaidya K, Saha S, Yousafzai MT, Hemlock C, Longley A, et al. Healthcare Utilization Patterns for Acute Febrile Illness in Bangladesh, Nepal, and Pakistan: Results from the Surveillance for Enteric Fever in Asia Project. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S248–56.

https://academic.oup.com/cid/article/71/Supplement_3/S248/6013565. 

7. Longley AT, Hemlock C, Date K, Luby SP, Andrews JR, Saha SK, et al. Illness Severity and Outcomes Among Enteric Fever Cases From Bangladesh, Nepal, and Pakistan: Data From the Surveillance for Enteric Fever in Asia Project, 2016–2019. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S222–31.

https://academic.oup.com/cid/article/71/Supplement_3/S222/6013556?login=false. 

8. Tamrakar D, Vaidya K, Yu AT, Aiemjoy K, Naga SR, Cao Y, et al. Spatial Heterogeneity of Enteric Fever in 2 Diverse Communities in Nepal. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S205–13.

https://academic.oup.com/cid/article/71/Supplement_3/S205/6013560. 

9. Da Silva KE, Tanmoy AM, Pragasam AK, Iqbal J, Sajib MSI, Mutreja A, et al. The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study. The Lancet Microbe. 2022 Aug;3(8):e567–77.

https://www.sciencedirect.com/science/article/pii/S2666524722000933. 

10. Hemlock C, Luby SP, Saha S, Qamar F, Andrews JR, Saha SK, et al. Utilization of Blood Culture in South Asia for the Diagnosis and Treatment of Febrile Illness. Clinical Infectious Diseases. 2020 Dec 1;71(Supplement_3):S266–75.

https://academic.oup.com/cid/article/71/Supplement_3/S266/6013568. 

11. Shrestha S, Da Silva KE, Shakya J, Yu AT, Katuwal N, Shrestha R, et al. Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance. Wunder EA, editor. PLoS Negl Trop Dis. 2024 Feb 8;18(2):e0011912. 

https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0011912. 

12. LeBoa C, Shrestha S, Shakya J, Naga SR, Shrestha S, Shakya M, et al. Environmental sampling for typhoidal Salmonellas in household and surface waters in Nepal identifies potential transmission pathways. Hasker E, editor. PLoS Negl Trop Dis. 2023 Oct 18;17(10):e0011341. 

https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0011341.Â